04/08/2024 4:09 PM | Paradigm Biocapital Advisors LP (Filed by) Y-mAbs Therapeutics (Subject)
| Form SC 13G | |
03/14/2024 4:01 PM | TAGLIAFERRI MARY (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 8:17 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 5:17 AM | TAGLIAFERRI MARY (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/07/2024 4:02 PM | Rajah Vignesh (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:49 PM | Smith Susan Laura (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:40 PM | Rajah Vignesh (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/05/2024 6:05 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 5:05 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 4:04 PM | Y-mAbs Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2024 2:59 PM | ACORN BIOVENTURES, L.P. (Filed by) Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024 4:54 PM | Lund-Hansen Torben (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:56 PM | Wilms Joris (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:58 PM | Lisby Steen (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 5:00 PM | Smith Susan Laura (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 5:02 PM | Rajah Vignesh (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:48 PM | Kruse Bo (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 4:52 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 5:45 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 3:15 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 6:40 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 3:40 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 7:27 AM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:26 AM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 4:25 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 4:25 PM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 4:14 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 4:15 PM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 4:14 PM | WG Biotech ApS (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 4:15 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 3:47 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 4:15 PM | Rossi Michael J (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/08/2023 4:16 PM | Rossi Michael J (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 4:19 PM | Gad Thomas (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 3:09 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 8:00 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/09/2023 5:00 PM | TYAGI ASHU (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:00 PM | HEALY JAMES (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:01 PM | GILL DAVID N (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:02 PM | Ber Gerard (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:04 PM | Wedell-Wedellsborg Johan (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Your Money is Not Safe (Ad) Biden Deploys Phase 1 Fednow Digital Currency
Discover how to legally "opt-out" of the digital dollar today.
No matter what they say, it's not something that will help you.
If you don't take the action steps shown below… CLICK HERE TO GET YOUR GUIDE NOW |
06/09/2023 5:05 PM | Hamill Laura (Reporting) Y-mAbs Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:30 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 8:41 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2023 11:15 PM | Y-mAbs Therapeutics (Filer)
| Form EFFECT | |
04/28/2023 5:08 AM | Y-mAbs Therapeutics (Filer)
| Form DEF 14A | |
04/28/2023 5:09 AM | Y-mAbs Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023 5:11 AM | Y-mAbs Therapeutics (Filer)
| Form ARS | |